Home FDA panel backs Novo Nordisk injection for obesity
 

Keywords :   


FDA panel backs Novo Nordisk injection for obesity

2014-09-12 00:55:12| Biotech - Topix.net

Federal health experts say Novo Nordisk's diabetes drug Victoza should be approved for a new use in treating obesity. The panel of Food and Drug Administration advisers voted 14-1 that the injectable drug's benefits outweigh its risks for patients who are obese or dangerously overweight.

Tags: panel novo injection backs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »